SCHEMBL5686105

SCHEMBL5686105

C1=Cc2ccccc2SN1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.34
GAA P10253 2/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
BCHE P06276 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAOA P21397 1/20 0.31
CNR1 P21554 1/20 0.31
ACHE P22303 1/20 0.31
PTGS1 P23219 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2C P28335 1/20 0.31
PTGS2 P35354 1/20 0.31
SNCA P37840 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8274 1.00 PARP1 (0.34) PARP1GAAMAPTMEN1CYP1A2
SCHEMBL3187256 0.98 PARP1 (0.33) PARP1GAAMAPTMEN1CYP1A2
Hydrochloric Acid SCHEMBL6424271 0.98 PARP1 (0.38) PARP1GAAMAPTMEN1CYP1A2
Ammonia Solution, Strong SCHEMBL10515014 0.98 PARP1 (0.33) PARP1GAAMAPTMEN1CYP1A2
SCHEMBL38654629 0.98 PARP1 (0.33) PARP1GAAMAPTMEN1CYP1A2
Fluoride SCHEMBL28896860 0.96 PARP1 (0.32) PARP1GAAMAPT
Hydrochloric Acid SCHEMBL8939837 0.96 PARP1 (0.36) PARP1GAAMAPT
Formaldehyde SCHEMBL28424513 0.94 PARP1 (0.31) PARP1
SCHEMBL28600218 0.87 PARP1 (0.32) PARP1
Phenothiazine SCHEMBL28347846 0.85 NOX1 (0.59) GAAMAPTMEN1CYP1A2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633743-A1 CYCLIC AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATION-RELATED DISORDERS MEDIATED BY BRADYKININ Amgen, Inc. (US) 2006-03-15 EP disclosed
EP-1631542-A1 BICYCLIC COMPOUNDS HAVING BRADYKININ RECEPTORS AFFINITY AND PHARMACEUTICAL COMPOSITIONS THEREOF Amgen, Inc. (US) 2006-03-08 EP disclosed
WO-2004092164-A1 CYCLIC AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATION-RELATED DISORDERS MEDIATED BY BRADYKININ AMGEN, INC. (US) 2004-10-28 WO disclosed
WO-2004092116-A1 BICYCLIC COMPOUNDS HAVING BRADYKININ RECEPTORS AFFINITY AND PHARMACEUTICAL COMPOSITIONS THEREOF AMGEN, INC. (US) 2004-10-28 WO disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed